RanBPM, a scaffolding protein in the immune and nervous systems

Journal of Neuroimmune Pharmacology

Volumn 2, Issue 3, 2007, Pages 290-295

  Murrin, L Charles ^a   Talbot, Jeffery N ^b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b OHIO NORTHERN UNIVERSITY   (United States)

Author keywords

LISH CTLH domain; RanBP9; RanBPM; Scaffolding proteins; Signal transduction; SPRY domain

Indexed keywords

NUCLEAR MATRIX PROTEIN; NUCLEAR PROTEIN; RAN BINDING PROTEIN 9; RAN PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; GENETICS; HUMAN; IMMUNE SYSTEM; METABOLISM; MOLECULAR GENETICS; NERVOUS SYSTEM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; IMMUNE SYSTEM; MOLECULAR SEQUENCE DATA; NERVOUS SYSTEM; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; RAN GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 34547702087     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-007-9079-x     Document Type: Article

References (35)

1. Beddow AL, Richards SA, Orem NR, Macara IG (1995) The Ran/TC4 GTPase-binding domain: identification by expression cloning and characterization of a conserved sequence motif. Proc Natl Acad Sci USA 92:3328-3332
2. Brannetti B, Helmer-Citterich M (2003) iSPOT: a web tool to infer the interaction specificity of families of protein modules. Nucleic Acids Res 31:3709-3711
3. Brannetti B, Zanzoni A, Montecchi-Palazzi L, Cesareni G, Helmer-Citterich M (2001) iSPOT: a web tool for the analysis and recognition of protein domain specificity. Compar Funct Genom 2:314-318
4. Brunkhorst A, Karlen M, Shi J, Mikolajczyk M, Nelson MA, Metsis M, Hermanson O (2005) A specific role for the TFIID subunit TAF4 and RanBPM in neural progenitor differentiation. Mol Cell Neurosci 29:250-258
5. Cheng L, Lemmon S, Lemmon V (2005) RanBPM is an L1-interacting protein that regulates L1-mediated mitogen-activated protein kinase activation. J Neurochem 94:1102-1110
6. Denti S, Sirri A, Cheli A, Rogge L, Innamorati G, Putignano S, Fabbri M, Pardi R, Bianchi E (2004) RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1. J Biol Chem 279:13027-13034
7. Emberley ED, Gietz RD, Campbell JD, HayGlass KT, Murphy LC, Watson PH (2002) RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer. BMC Cancer 2:28
8. Emes RD, Ponting CP (2001) A new sequence motif linking lissencephaly, Treacher Collins and oral-facial-digital type 1 syndromes, microtubule dynamics and cell migration. Hum Mol Genet 10:2813-2820
9. Gerlitz G, Darhin E, Giorgio G, Franco B, Reiner O (2005) Novel functional features of the Lis-H domain: role in protein dimerization, half-life and cellular localization. Cell Cycle 4:1632-1640
10. Giblin PA, Lemieux RM (2006) LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics. Curr Pharm Des 12:2771-2795
11. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 95:114-119
12. Jang YJ, Ji JH, Ahn JH, Hoe KL, Won M, Im DS, Chae SK, Song S, Yoo HS (2004) Polo-box motif targets a centrosome regulator, RanGTPase. Biochem Biophys Res Commun 325:257-264
13. Kay BK, Williamson MP, Sudol M (2000) The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 14:231-241
14. Kramer S, Ozaki T, Miyazaki K, Kato C, Hanamoto T, Nakagawara A (2005) Protein stability and function of p73 are modulated by a physical interaction with RanBPM in mammalian cultured cells. Oncogene 24:938-944
15. Letunic I, Goodstadt L, Dickens NJ, Doerks T, Schultz J, Mott R, Ciccarelli F, Copley RR, Ponting CP, Bork P (2002) Recent improvements to the SMART domain-based sequence annotation resource. Nucleic Acids Res 30:242-244
16. Macias MJ, Wiesner S, Sudol M (2002) WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett 513:30-37
17. Mateja A, Cierpicki T, Paduch M, Derewenda ZS, Otlewski J (2006) The dimerization mechanism of LIS1 and its implication for proteins containing the LisH motif. J Mol Biol 357:621-631
18. Menon RP, Gibson TJ, Pastore A (2004) The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre. J Mol Biol 343:43-53
19. Murrin LC, Thomas MP (2007) Molecular, cellular and physiological mechanisms of psychiatric disorders. In: Gendelman HE, Ikezu T (eds) The neuroimmune system in psychiatric disorders. Springer, Berlin (in press)
20. Nakamura M, Masuda H, Horii J, Kuma K, Yokoyama N, Ohba T, Nishitani H, Miyata T, Tanaka M, Nishimoto T (1998) When overexpressed, a novel centrosomal protein, RanBPM, causes ectopic microtubule nucleation similar to γ-tubulin. J Cell Biol 143:1041-1052
21. Nishitani H, Hirose E, Uchimura Y, Nakamura M, Umeda M, Nishii K, Mori N, Nishimoto T (2001) Full-sized RanBPM cDNA encodes a protein possessing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex. Gene 272:25-33
22. Rao MA, Cheng H, Quayle AN, Nishitani H, Nelson CC, Rennie PS (2002) RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor. J Biol Chem 277:48020-48027
23. Rexach M, Blobel G (1995) Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell 83:683-692
24. Sattler M, Salgia R (2007) c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr Oncol Rep 9:102-108
25. Talbot JN, Toews ML, Bylund DB, Murrin LC (2003) Mu opioid receptor-stimulated ERK activation in HEK293 cells is inhibited by the overexpression of RanBPM. Soc Neurosci Abs 28:802.5
26. Talbot JN, Toews ML, Murrin LC (2004) The effects of RanBPM on agonist-mediated endocytosis of the mu opioid receptor. FASEB J 18:A586
27. Talbot JN, Toews ML, Murrin LC (2005) Regulation of mu opioid receptor internalization by the accessory protein RanBPM. FASEB J 19:A1098
28. Tang X, Zhang J, Cai Y, Miao S, Zong S, Koide SS, Wang L (2004) Sperm membrane protein (hSMP-1) and RanBPM complex in the microtubule-organizing centre. J Mol Med 82:383-388
29. Togashi H, Schmidt EF, Strittmatter SM (2006) RanBPM contributes to Semaphorin3A signaling through plexin-A receptors. J Neurosci 26:4961-4969
30. Wang D, Li Z, Messing EM, Wu G (2002a) Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM. J Biol Chem 277:36216-36222
31. Wang Y, Marion SE, Li X, Duttenhofer I, Debatin K, Hug H (2002b) HIPK2 associates with RanBPM. Biochem Biophys Res Commun 297:148-153
32. Wang D, Li Z, Schoen SR, Messing EM, Wu G (2004) A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling. Biochem Biophys Res Commun 313:320-326
33. Wu Y, Sun X, Kaczmarek E, Dwyer KM, Bianchi E, Usheva A, Robson SC (2006) RanBPM associates with CD39 and modulates ecto-nucleotidase activity. Biochem J 396:23-30
34. Yokoyama N, Hayashi N, Seki T, Pante N, Ohba T, Nichii K, Kuma K, Hayashida T, Miyata T, Aebi U, Fukui M, Nishimoto T (1995) A giant nucleopore protein that binds Ran/TC4. Nature 376:184-188
35. Zou Y, Lim S, Lee K, Deng X, Friedman E (2003) Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M. J Biol Chem 278:49573-49581